{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:37:45Z","timestamp":1773387465892,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"12","funder":[{"name":"That Man May See Foundation"},{"name":"Huang Pacific Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,11,25]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cytomegalovirus (CMV) anterior uveitis is a recognised cause of anterior uveitis in immunocompetent patients and is preventable cause of vision loss. Ocular sequelae include corneal endothelial damage which can cause corneal oedema and failure, as well as glaucoma. Recurrences of inflammation are common and therefore patients are often exposed to long-term therapy. Oral therapy is available in the form of valganciclovir, although with the caveat of systemic side effects such as bone marrow suppression and renal failure necessitating regular interval laboratory monitoring. Recent reports have demonstrated that topical 2% ganciclovir solution may offer promising treatment outcomes in patients with CMV anterior uveitis with superior safety, cost-effectiveness and convenience profiles. An investigation into the relative equipoise of these therapies is warranted for these reasons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Systemic and Topical Control of Cytomegalovirus Anterior uveitis: Treatment Outcomes (STACCATO) trial is designed as a multicentre, block randomised by site, double-masked, placebo-controlled trial comparing the efficacy of oral valganciclovir, 2% topical ganciclovir and placebo in treating PCR-proven CMV anterior uveitis. Participant clinical evaluation will occur at three study time points by a masked study ophthalmologist over a 28-day period to assess resolution of ocular inflammation (secondary outcome). A control group will provide additional information about the possible impact that the infected host\u2019s immune response may play in controlling local viral replication. The primary analysis is an analysis of covariance (three arms) correcting for baseline to compare quantitative CMV viral load in the anterior chamber (AC) aqueous fluid before and 7\u2009days after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The University of California San Francisco Committee on Human Research and the Khon Kaen University Institutional Review Board have given ethical approval. The results of this trial will be presented at local and international meetings and submitted for peer-reviewed journals for publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03576898\">NCT03576898<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-033175","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T04:55:13Z","timestamp":1576817713000},"page":"e033175","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03576898","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct03576898","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jaskirat S","family":"Takhar","sequence":"first","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"John Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlin S","family":"Joye","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Touro University California College of Osteopathic Medicine, Vallejo, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanapong","family":"Somkijrungroj","sequence":"additional","affiliation":[{"name":"Ophthalmology, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand"},{"name":"Ophthalmology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wipada","family":"Laovirojjanakul","sequence":"additional","affiliation":[{"name":"Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ping","family":"Lin","sequence":"additional","affiliation":[{"name":"Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Ophthalmology, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis C","family":"Porco","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-1457","authenticated-orcid":false,"given":"Jeremy D","family":"Keenan","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-5016","authenticated-orcid":false,"given":"Elisabeth A","family":"Gebreegziabher","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerami D","family":"Seitzman","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Rose-Nussbaumer","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Kaiser Permanente, Redwood City, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy A","family":"Doan","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha R","family":"Acharya","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"2025121514143445000_9.12.e033175.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)00961-2"},{"key":"2025121514143445000_9.12.e033175.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-010-1510-y"},{"key":"2025121514143445000_9.12.e033175.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.09.001"},{"key":"2025121514143445000_9.12.e033175.4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.8.1030"},{"key":"2025121514143445000_9.12.e033175.5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9394(14)72610-8","article-title":"A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis","volume":"120","author":"McCann","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.12.015"},{"key":"2025121514143445000_9.12.e033175.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.07.057"},{"key":"2025121514143445000_9.12.e033175.8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjopt.2011.10.001","article-title":"Cytomegalovirus-Related corneal endotheliitis: a review article","volume":"27","author":"Alfawaz","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.04.053"},{"key":"2025121514143445000_9.12.e033175.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.03.020"},{"key":"2025121514143445000_9.12.e033175.11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/ICO.0b013e3181c325e2","article-title":"Detection of cytomegalovirus DNA from cytomegalovirus corneal endotheliitis after penetrating keratoplasty","volume":"29","author":"Sonoyama","year":"2010","journal-title":"Cornea"},{"key":"2025121514143445000_9.12.e033175.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.10.031"},{"key":"2025121514143445000_9.12.e033175.13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajo.2017.02.026","article-title":"In Vivo Characteristics of Corneal Endothelium\/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection","volume":"178","author":"Abou Shousha","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ICO.0000000000001797","article-title":"Topical ganciclovir for prophylaxis of cytomegalovirus Endotheliitis in endothelial keratoplasty","volume":"38","author":"Basilious","year":"2019","journal-title":"Cornea"},{"key":"2025121514143445000_9.12.e033175.15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00417-014-2782-4","article-title":"Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients","volume":"252","author":"Accorinti","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.16","doi-asserted-by":"crossref","DOI":"10.1038\/srep43349","article-title":"Enhanced cytomegalovirus infection in human trabecular meshwork cells and its implication in glaucoma pathogenesis","volume":"7","author":"Choi","year":"2017","journal-title":"Sci Rep"},{"key":"2025121514143445000_9.12.e033175.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-018-0917-9","article-title":"Cytomegalovirus-Related uncontrolled glaucoma in an immunocompetent patient: a case report and systematic review","volume":"18","author":"Xi","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/09273948.2018.1498109","article-title":"Review for disease of the year: treatment of viral anterior uveitis: a perspective","volume":"26","author":"Zandi","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025121514143445000_9.12.e033175.19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2147\/OPTH.S60394","article-title":"Current aspects on the management of viral uveitis in immunocompetent individuals","volume":"9","author":"Pleyer","year":"2015","journal-title":"OPTH"},{"key":"2025121514143445000_9.12.e033175.20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","article-title":"Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy","volume":"158","author":"CC","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-016-0078-z","article-title":"Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis","volume":"6","author":"Wong","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2025121514143445000_9.12.e033175.22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1442-9071.2012.02888.x","article-title":"Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty","volume":"41","author":"CC","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"2025121514143445000_9.12.e033175.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2016-000061","article-title":"Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis","volume":"2","author":"Keorochana","year":"2017","journal-title":"BMJ Open Ophth"},{"key":"2025121514143445000_9.12.e033175.24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jop.2016.0138","article-title":"Topical ganciclovir in cytomegalovirus anterior uveitis","volume":"33","author":"Antoun","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025121514143445000_9.12.e033175.25","first-page":"517","article-title":"Cytomegalovirus-Associated anterior segment inflammation","volume":"5","author":"A CS","year":"2011","journal-title":"Expert Review of Ophthalmology"},{"key":"2025121514143445000_9.12.e033175.26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"Statement: defining standard protocol items for clinical trials","volume":"2013","author":"Chan A-W","year":"2013","journal-title":"Ann Intern Med"},{"key":"2025121514143445000_9.12.e033175.27","first-page":"151","article-title":"Seroprevalence of cytomegalovirus, Toxoplasma and parvovirus in pregnancy","volume":"41","author":"Wong","year":"2000","journal-title":"Singapore Med J"},{"key":"2025121514143445000_9.12.e033175.28","first-page":"93","article-title":"Immune status in congenital infections by torch agents in pregnant Thais","volume":"15","author":"Taechowisan","year":"1997","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2025121514143445000_9.12.e033175.29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.7_Spec_No.779"},{"key":"2025121514143445000_9.12.e033175.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02565.x"},{"key":"2025121514143445000_9.12.e033175.31","unstructured":"Roche Pharmaceuticals . Valganciclovir package insert. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2001\/21304lbl.pdf"},{"key":"2025121514143445000_9.12.e033175.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.059"},{"key":"2025121514143445000_9.12.e033175.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-007-9090-5"},{"key":"2025121514143445000_9.12.e033175.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-013-0268-2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-033175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:14:45Z","timestamp":1765836885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-033175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,19]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1136\/bmjopen-2019-033175"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-033175","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}